Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 88 Results

Intervention Indication Therapeutic Area Year Actions
SA-237 for neuromyelitis optica and neuromyelitis optica spectrum disorders Satralizumab (SA237; RG6168) Neuromyelitis optica , Neuromyelitis optica spectrum disorders Neurology , Ophthalmology 2017 View  |  Download
SAGE-547 for super-refractory status epilepticus Brexanolone (SAGE-547; Zulresso) Super-refractory status epilepticus (SRSE) Neurology 2017 View  |  Download
SAR443820 for treating amyotrophic lateral sclerosis (ALS) SAR443820 (DNL788) Amyotrophic lateral sclerosis Neurology 2023 View  |  Download
Sarizotan for Respiratory Symptoms Associated Rett Syndrome Sarizotan (EMD-128130) Rett syndrome Genetic Disorders , Neurology 2018 View  |  Download
Selumetinib for neurofibromatosis type 1 Selumetinib (AZD6244; ARRY-142886) Neurofibromatosis Neurology 2019 View  |  Download
Selumetinib for treating symptomatic, inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in adults Selumetinib (AZD6244; ARRY-142886) Plexiform neurofibromas Neurological Cancer , Neurology 2023 View  |  Download
Sodium phenylbutyrate-ursodoxicoltaurine for treating amyotrophic lateral sclerosis Sodium phenylbutyrate-ursodoxicoltaurine Amyotrophic lateral sclerosis Neurology 2022 View  |  Download
STS101 for the acute treatment of migraine STS-101 (TO-2070, dihydroergotamine) Migraine Neurology 2022 View  |  Download
Sumatriptan-Naproxen for the treatment of acute migraine Sumatriptan-Naproxen Migraine Neurology 2024 View  |  Download
Tideglusib for congenital myotonic dystrophy Tideglusib (AMO-02; Zentylor; Nypta; NP031112) Myotonic dystrophy Genetic Disorders , Musculoskeletal System , Neurology 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications